Document:

Exhibit 10.2

 

STELLAR MANUFACTURING AGREEMENT

 

This Stellar Manufacturing Agreement (“Agreement”), effective the 1st day of July, 2009 (the “Effective Date”), by and between Stellar Technologies, Inc., a Minnesota corporation (“Stellar”) and Nevro Corp., a Delaware corporation, having a place of business at 411 Acacia Avenue, Palo Alto, CA 94306 (“Customer”) (Stellar and Customer are the “Party[ies]”).

 

In consideration of the mutual covenants contained in this Agreement, the receipt and sufficiency of which are hereby acknowledged, Customer and Stellar agree as follows:

 

1.)                                  Appointment.  Customer hereby appoints Stellar as its supplier of all percutaneous leads and percutaneous lead extenders for neurological stimulation and related services that Customer orders from Stellar during the Contract Term.  All plans, designs and specifications used by Stellar in manufacturing or providing any Products and Services are designed solely by Customer and are owned exclusively by Customer.  Customer agrees to indemnify and hold Stellar harmless from any claims, judgments, penalties, recalls and attorney fees arising from any third-party allegations that Customer’s plans, designs and specifications for the Products infringe on or violate any third party’s patents, trade secrets, proprietary rights or other intellectual property rights.  Stellar will cooperate with Customer’s efforts to obtain regulatory approval for its Products from governmental authorities (“Regulatory Approvals”) without conveying to Customer or any governmental authorities any right, title or interest in its Confidential Information and Intellectual Property as defined herein.

 

2.)                                  Definitions.  For purposes of this Agreement, “Product(s)” means percutaneous leads and percutaneous lead extenders for neurological stimulation, including parts, components, supplies and finished devices, manufactured by Stellar for Customer.  “Service(s)” means any work or other services performed by Stellar for Customer, including without limitation any process and any work that may increase the effectiveness, efficiency or safety of any Products.  “Purchase Order Acknowledgment” refers to Stellar’s Purchase Order Acknowledgment as defined in Section 5; it does not refer to any of Customer’s Purchase Orders, requests for proposal, requests for quotations, shipping documents and other Customer documents relating to the Products and Services (collectively, “Customer Records”).  “Subcontractor” refers to Customer’s subassembly contractors or other subcontractors; “Subcontractor” does not include any buyer, licensee or other transferee of Customer or Customer’s assets, including without limitation a successor, assignee or transferee under a Customer Sale or Product/Service Transfer as defined in Section 22.  “Buyer” refers to a successor, assignee or transferee under a Customer Sale or Product/Service Transfer as defined in Section 22.  Buyer is deemed to assume all of Customer’s obligations under this Agreement, subject to the provisions of Section 25.

 

3.)                                  Term of Agreement.  This Agreement is for a term of five (5) years, beginning the Effective Date, and will automatically renew for an additional year on each subsequent annual anniversary date, unless terminated by either party in writing at least thirty (30) days prior to the expiration of the then-current term (“Contract Term”).  All Purchase Orders issued or approved by Stellar prior to the expiration date of the then-current Contract Term shall remain in effect 

 

 

through the date of Stellar’s last scheduled shipment made under that Purchase Order, even if manufacturing and shipment occur after the expiration or other termination of this Agreement (“Last Shipment”).  The terms of this Agreement shall also remain in effect through the Last Shipment.  In addition, Customer’s Indemnity described in Section 17 and the Continuation Charge described in Section 24 shall survive the expiration or termination of this Agreement, subject to the terms hereof.

 

4.)                                  Voluntary Termination by Stellar or Customer.  Stellar may terminate this Agreement at-will at any time on six (6) months’ notice (“Stellar Voluntary Termination”), without incurring any liability or obligation to Customer, except Customer’s right to a Last Time Buy under Section 12.  Customer may make a Last Time Buy at any time through the last day of the six (6)-month notice period.  In the event of a Stellar Voluntary Termination, Customer is not liable for the Continuation Charge.

 

Customer may also terminate this Agreement at-will at any time (“Customer Voluntary Termination”), provided Customer pays Stellar all amounts due or to become due under this Agreement, together with the Continuation Charge, immediately upon receipt of Stellar’s invoices for such amounts.  The amounts due or to become due include, without limitation: (a) the Price and other sums due under Section 10; (b) any costs under Section 11; (c) any remedies for Customer’s Default under Sections 22 and 23; (d) the Continuation Charge; and (e) any [***] and other costs under Exhibit A, Price Terms.

 

If Customer or Buyer is unable to obtain FDA approval of the Products, this shall also be deemed a Customer Voluntary Termination and Customer and Buyer shall remain liable for all amounts due or to become under this Agreement, except for the Continuation Charge.

 

5.)                                  Preferred Supplier Clause, Purchase Orders and Purchase Order Acknowledgments.  Customer designates Stellar as its preferred supplier of the Products and Services throughout the Contract Term.  Customer will in good faith negotiate exclusively with Stellar for a period of [***] days after giving Stellar written notice of its interest in negotiations before engaging any other suppliers or vendors of the Products and Services.

 

During the Contract Term, Customer or its Subcontractor(s) shall submit its own purchase orders or other requests for Products and Services to Stellar (“collectively, “Purchase Order(s)”).  Customer’s Purchase Orders may include such terms as components, price, quantity, delivery schedule (including proposed shipping dates and quantities), whether the Products will be delivered to the Customer or Subcontractor, plans, drawings, material specifications, process specifications, and other Customer specifications and requirements (“Terms”).

 

Within [***] business days after receipt of a Purchase Order, Stellar will issue a Purchase Order Acknowledgment signed by Stellar (“Purchase Order Acknowledgment”) accepting the Terms of the Purchase Order, except [***].  Stellar may amend (a) [***], and (b) [***].  Any such revisions to the [***] shall be incorporated into, and become a Term of, the Purchase Order.  Customer may not revise Stellar’s [***] Term except upon prior written consent of Stellar’s Chief Executive Officer.  All Purchase Orders are subject to the terms of this Agreement.

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

2

 

6.)                                  Right to Reject.  Stellar is only obligated to provide Products and Services under the Terms of Purchase Orders that it has approved in writing, subject to Changes, as defined in Section 7.  Stellar may [***].

 

7.)                                  Changes.  For purposes of this Agreement and any Purchase Order, “Change” means a change in materials, process, procedures or facilities that materially affects the Product or Service.  “Change” does not include alterations in the Product or Service characteristics that fit within the Customer’s specifications that are in effect on the date Stellar performs such work, and it does not include “Variations” as defined below.  Furthermore, Stellar does not make any Changes or Variations to Customer’s plans, designs and specifications for any Products or Services.

 

Stellar agrees to inform Customer of any process change that affects the fit, form or function of the Products.  Stellar agrees to notify Customer of any Changes in advance so that Customer may determine whether the Changes could affect the quality of a finished Product or Service.  Such notification shall be made in sufficient detail to allow the Customer to determine the impact of such Changes, if any, upon the affected finished Product or Service.

 

Stellar is not required to provide Customer prior notice in connection with the following variations in the following manufacturing processes, materials and other activities, provided Stellar complies with all specifications, drawings, material specifications, process specifications, and other Customer requirements as specifically set forth in the Purchase Orders (collectively, “Variations”):

 

(a)                                 Stellar may purchase materials, tools and any other items [***]appropriate for performance of any Purchase Order from multiple vendors, provided such purchases meet the applicable Customer specifications;

 

(b)                                 Stellar may [***] provided the relevant processing method does not change.  For example, and not by way of limitation, Stellar may [***].  The material processing will be verified by inspection and certified to Customer’s written specifications.  Part numbers are not machine-specific;

 

(c)                                  Stellar may [***], including, for example, [***].  Such [***] may include, without limitation, [***]; and

 

(d)                                 Stellar may [***].

 

8.)                                  Certificate of Conformance.  Stellar shall provide a written Certificate of Conformance with each delivery of Products or Services.

 

9.)                                  Delivery.  Stellar shall deliver Products and Services to Customer, [***], [***].  Packaging and delivery shall be made in accordance with Stellar’s policies in effect on the date of delivery.  Title to, and all risk of loss or damage with respect to, the Products and Services shall pass to Customer upon [***].  Delivery is subject to Stellar’s receipt of all necessary information and documentation from Customer, including all required certificates, licenses and documents required for export of the Products and Services.  Stellar is not liable for any delays in delivery beyond the reasonable control of Stellar and Stellar’s suppliers, including but not limited to:  (a) delays caused by unavailability or shortages of labor, fuel, power, materials, 

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

3

 

Products and Services, at customary and reasonable prices, rates and times; (b) natural disasters, acts of war, fire, flood or other casualty, strike, riot, or governmental interference; (c) failure or destruction of plant or equipment arising from any cause whatsoever; or (d) transportation delays.  Stellar will inform Customer or its Subcontractor(s) of any delays in delivery of Product within [***] days after knowledge of the delays.  Stellar will not charge increased unit prices under Exhibit A, Section 7, for its own delays.  Stellar is not responsible for [***] unless specified in the Purchase Order, in which event such [***] shall be based on [***].  Regardless of whether Stellar [***], Stellar is [***], and Customer [***], and instead [***].

 

10.)                           Price and Payment.  Customer shall remit payment to Stellar for all Products and Services within [***] days after the date of Stellar’s delivery, [***].  Customer agrees to pay Stellar the full amount of the price of the Products and Services set forth in each Purchase Order and any Schedules and Addenda referenced therein, plus any sums payable to Stellar under this Agreement (collectively, “Price”), as they accrue.  All of Stellar’s invoices shall be due within [***] days after the date of the invoice except invoices for (a) deliveries of Products and Services (which are due and payable within [***] days after the date of delivery) and (b) amounts immediately due and payable under this Agreement.  Invoices due within [***] days after the date of the invoice include, without limitation, invoices for modifications, revisions and cancellations under Section 11 and invoices for BAL seals under Exhibit A, Price Terms, Section 6.  If there is any inconsistency between the payment terms of any documents, the payment terms contained in this Section 10 govern.  However, if Customer is in Default, all Purchase Orders and invoices shall be immediately due and payable.  Customer shall pay all federal, state, municipal and other government taxes (such as sales, use, and similar taxes), as well as import or customs duties, license fees and similar charges relating to all sales.  Exemption certificates must be presented by Customer prior to delivery if they are to be honored.  Stellar may charge interest on all unpaid invoices at a rate equal to the lesser of (a) [***] per month on the unpaid balance, calculated from the date due; or (b) the highest rate allowed by law.  If Stellar accepts payment by check, Customer agrees to pay Stellar an administrative fee of $[***] for each check that is dishonored, returned “NSF”, or which is subject to a “stop payment” order, [***]

 

11.)                           Purchase Order Modification or Cancellation by Customer or Stellar.  Customer may modify or cancel a Purchase Order within [***] days after the date of the Purchase Order (“[***] Period”).  Such modification or cancellation must be in writing and received by Stellar within the [***] Period or it is void.

 

Upon receipt of such timely notice (that is, within the [***] Period), if Customer notifies Stellar that it is only delaying delivery for up to [***] days after the date specified in the Purchase Order (“Delayed Delivery”), Customer will pay the cost of (a) all finished Products and Services manufactured by Stellar, including without limitation Products and Services in Stellar’s and Customer’s inventory and in shipment and (b) Stellar’s losses relating in any way to precious metals materials that Stellar returns to its precious metals suppliers, plus the related costs of shipping, handling and any losses due to fluctuations in currency exchange rates.

 

Alternatively, upon receipt of such timely notice (that is, within the [***] Period), if (i) Customer modifies any Terms other than a Delayed Delivery (for example but not by way of limitation, by changing any revisions to the drawings and specifications), or (ii) Customer cancels the Purchase Order, or (iii) Customer fails to order delivery within the Delayed Delivery period, Stellar will calculate, and Customer will immediately pay Stellar, the cost of all (x) 

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

4

 

finished Products and Services manufactured or provided by Stellar, including without limitation Products and Services in Stellar’s and Customer’s inventory and in shipment, (y) all work in process (including Products and Services) and (z) [***].

 

If Customer delays delivery of any part of a Purchase Order more than [***] after the date of the Purchase Order [***], the unit price shall also be recalculated and added to the Price, as provided in Exhibit A, Price Terms, Section 7.

 

If Customer makes any modification or other revision to the drawings and specifications for a Product or Service, Customer shall pay all of Stellar’s costs for undertaking or making such modification or revision.  These costs are in addition to: (A) the amounts referenced in the preceding paragraphs of Section 11 and (B) any [***] to the unit price under Exhibit A, Price Terms, Section 2.  Customer is liable for these costs regardless of whether such modification or revision is made with timely notice under Section 11.

 

The amounts due under Section 11 will [***] and shall be payable as provided in Section 10.

 

Stellar reserves the right to cancel any Purchase Order and any delivery thereunder, at any time, as a result of Customer’s Default (as defined in Section 22) without incurring any liability or obligation to Customer, subject to the Last Time Buy, as defined in Section 12.

 

The remedies contained in Section 11 are in addition to all other remedies available to Stellar for Customer’s Default.

 

12.)                           Last Time Buys Upon Expiration or Termination of Agreement or Termination of Purchase Order by Stellar.  Upon expiration or termination of this Agreement, or upon termination of a Purchase Order by Stellar, Stellar shall take reasonable measures to cease any ongoing Services or production of Product(s) and limit further expenses associated with such ongoing production, except for the Last Time Buy.  Notwithstanding the foregoing, upon expiration or termination of this Agreement, or upon termination of a Purchase Order by Stellar, then unless such termination is the result of Customer’s Default under Section 22, Customer shall have the right to place a last Purchase Order with multiple delivery dates (the “Last Time Buy”).  The last delivery date under any Last Time Buy shall not to exceed [***] months from the date of the Last Time Buy.  Any credit remaining on Customer’s account upon expiration or termination of this Agreement shall be refunded to Customer within [***] days after the latest of the expiration, termination or last delivery of Product pursuant to the Last Time Buy.  Any credit remaining on Customer’s account upon termination of any Purchase Order under Section 12 shall be refunded to Customer within [***] days after the later of the termination of the Purchase Order or last delivery of Product ordered pursuant to the Last Time Buy.

 

13.)                           Confidential Information.  During [***], Stellar and Customer may provide confidential and proprietary information and trade secrets regarding their respective products, processes, know-how, work and business to the other party.  Such information shall be deemed the confidential and proprietary information, or trade secrets, of the disclosing party, provided the disclosing party designates the information as “CONFIDENTIAL” in writing at the time of disclosure or within [***] after disclosure to the receiving party (“Confidential Information”).  Any Confidential Information disclosed by either party will remain the sole property of the 

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

5

 

disclosing party unless it (i) was rightfully known to the receiving party (without any restriction on disclosure or use) prior to its receipt from the disclosing party, or (ii) becomes part of the public domain or (iii) is disclosed to the receiving party by a third party not in violation of the disclosing party’s rights.  Each party shall take all necessary precautions to protect the other party’s Confidential Information.  Both parties agree, on behalf of themselves and their respective employees, agents, successors and assigns, that the receiving party will not, directly or indirectly: (a) reproduce, publish or disclose the disclosing party’s Confidential Information to any third party, or (b) use the disclosing party’s Confidential Information for any purpose except to perform this Agreement and any Purchase Order, without the prior written consent of the disclosing party.  The Chief Executive Officer of Stellar is the only person authorized to grant such written consent on behalf of Stellar.  Each party agrees to not disclose the other party’s Confidential Information under any court or other governmental order without giving immediate written notice of the order to the disclosing party so that the disclosing party may take legal action to prevent the disclosure.  On request, each party will return the other party’s Confidential Information and certify the return or destruction of all copies thereof, regardless of the medium in which it is maintained.  Either party may obtain a temporary restraining order and temporary and permanent injunctions to enforce Section 13 and to prevent or prohibit the imminent or actual disclosure or use of its Confidential Information.  The receiving party shall pay all of the disclosing party’s damages, attorneys’ fees, costs and disbursements arising from the receiving party’s imminent or actual violation of any term of Section 13.  Each party shall have the right to review and approve the other party’s procedures for handling records and Confidential Information, and may make such inspections as the disclosing party deems necessary to insure that the other party is properly safeguarding the disclosing party’s records and Confidential Information.  Each party’s obligations under Section 13 shall survive the termination or expiration of this Agreement and all Purchase Orders except as to information that does not qualify, or no longer qualifies, as Confidential Information under the terms of Section 13 (i-iii).  Customer further agrees that all information and records that it received from Stellar on or before the date of this Agreement is Stellar’s Confidential Information.

 

14.)                           Intellectual Property.  Stellar retains sole and exclusive right, title and interest in its Confidential Information, trade secrets, proprietary information, patents, trademarks, servicemarks and all other intellectual property (“Intellectual Property”).  Customer retains sole and exclusive right, title and interest in its Intellectual Property.  All Intellectual Property that Stellar uses or develops in connection with performing this Agreement relating in any manner to [***] is and remains the sole property of Stellar.  Stellar does not [***].  All changes and improvements to the [***] is and remains the sole property of Customer.  If Stellar and Customer develop new Intellectual Property while working together [***] (“Other IP”), Customer is the owner of the Other IP and Customer hereby grants to Stellar an irrevocable, worldwide, nonexclusive license to use such Other IP at no cost to Stellar.  Stellar and Customer agree to cooperate with each other in effecting assignments of and registering any Intellectual Property and Other IP to effect the foregoing, subject to their respective rights in their own Confidential Information and Intellectual Property.  This duty to cooperate shall survive the expiration or termination of this Agreement.

 

15.)                           Customer’s Right to Inspect Records.  Stellar agrees to provide records confirming Stellar’s compliance with an appropriate quality system for Customer’s review upon reasonable request.  Stellar should allow Customer, upon reasonable notice, to perform quality 

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

6

 

system audits at Stellar’s facility, including the review of applicable documentation.  These records may include the following quality controls:

 

(a)                                 Process controls;

 

(b)                                 Inspection records confirming appropriate calibrated measuring equipment and statistically valid sampling plans;

 

(c)                                  Records tracing Products and Services to the materials and processes used, and the dates of manufacture;

 

(d)                                 Products and Services labeled to insure proper identification and packed for shipment in accordance with packing and shipping requirements set forth in the Purchase Order; and

 

(e)                                  Stellar will maintain a Device Master File (“DMF”) for Products manufactured by Stellar.  Stellar hereby grants Customer a right of reference for such DMF solely for the purpose of developing and obtaining regulatory approval of Customer’s products incorporating Products.  Such right of reference does not allow Customer to access directly the DMF or to review and read the DMF.  Stellar shall retain records for each batch of Product manufactured pursuant to this Agreement for [***] years after the last delivery of such Product.

 

16.)                           Limited Warranty.  Stellar makes no warranty except as specifically set forth in Stellar’s Certificate of Conformance for the Products and Services listed in the Certificate of Conformance (“Limited Warranty”).  STELLAR MAKES NO OTHER WARRANTY, EXPRESS OR IMPLIED, INCLUDING WARRANTY OF TITLE AND IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE.

 

17.)                           Indemnification.  If Customer or any third party: (i) performs any operation, procedure or process involving any Products or Services, or (ii) assembles, installs, uses or manufactures any Products or Services, or (iii) transports or delivers any Products to any third party, Customer immediately assumes all liability for, and agrees to indemnify and hold Stellar harmless from all claims, damages, recalls, penalties and attorneys’ fees relating to, or arising from, the Products and Services.  In addition, Stellar is not liable for: (a) Customer’s designs, plans and specifications for the Products and Services; (b) Customer-supplied goods, including without limitation material, components, assemblies, and services, whether conforming or non-conforming, while in Stellar’s possession (“Customer Materials”); (c) non-conformities in any Products or Services created or occurring during Stellar’s handling, development, set-up, production, inspection, or provision of Services; and (d) non-conformities in any Products or Services created or occurring while in the possession of any third parties (collectively, (c-d), “Non-Conformities”).  Customer assumes all liability for, and agrees to indemnify and hold Stellar harmless from all claims, damages, recalls, penalties and attorneys’ fees relating to, or arising from, Customer’s designs, plans and specifications, Customer Materials and Non-Conformities (collectively, Section 17, “Customer’s Indemnity”).

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

7

 

18.)                           Remedy and Limitation of Damages.  Customer or Subcontractor shall inspect each shipment of Products and Services within [***] days after delivery (“Inspection Period”).  If any Products or Services do not conform to the Certificate of Conformance (collectively, “Defect[s]”, “Product Defect” or “Service Defect”), Customer or Subcontractor shall notify Stellar of such Defects within [***] days after the expiration of the Inspection Period or the Defects are waived.  [***]  Subject to Customer’s Indemnity, in the event of a Product Defect, Stellar’s [***] and Customer’s [***] shall be as follows: (a) that Stellar repair or replace the defective Products (or any defective part thereof) without charge; OR (b) that Stellar credit the Price of the defective Products (or any defective part thereof) to future Purchase Orders; OR (c) that Stellar refund the Price of the defective Products (or any defective part thereof), which alternative remedy (a, b, or c) shall be [***].  Stellar will issue a Return Material Acceptance (RMA) number for the return and replacement, repair or refund of the defective Product.  Defective Products will be repaired or scrapped and Customer will receive a credit for those that are scrapped.  IN NO EVENT SHALL STELLAR BE LIABLE FOR ANY CLAIM OR DAMAGE IN EXCESS OF THE PURCHASE PRICE OF THE DEFECTIVE PRODUCTS (OR ANY DEFECTIVE PARTS THEREOF) UNDER THE RELATED PURCHASE ORDER.  STELLAR IS NOT LIABLE FOR ANY OTHER CLAIMS OR DAMAGES, INCLUDING WITHOUT LIMITATION, DIRECT, INDIRECT, SPECIAL, CONSEQUENTIAL, PUNITIVE OR INCIDENTAL DAMAGES , RECALL OR ATTORNEYS’ FEES.  Subject to Customer’s Indemnity, in the event of a Service Defect, Stellar’s [***] and Customer’s [***] shall be as follows: (a) that Stellar repair or replace without charge defective Services provided by Stellar; OR (b) that Stellar credit the Price of defective Services provided by Stellar to future Purchase Orders; OR (c) that Stellar refund to Customer the Price of defective Services provided by Stellar, which alternative remedy (a, b, or c) shall be [***].  IN NO EVENT SHALL STELLAR BE LIABLE FOR ANY CLAIM OR DAMAGE IN EXCESS OF THE PURCHASE PRICE OF THE DEFECTIVE SERVICES PROVIDED BY STELLAR UNDER THE RELATED PURCHASE ORDER.  STELLAR IS NOT LIABLE FOR ANY OTHER CLAIMS OR DAMAGES, INCLUDING WITHOUT LIMITATION, DIRECT, INDIRECT, SPECIAL, CONSEQUENTIAL, PUNITIVE OR INCIDENTAL DAMAGES, RECALL OR ATTORNEYS’ FEES.

 

If there is a dispute as to whether any of Stellar’s Products or Services contain Defects, Customer and Stellar agree to submit the dispute to an independent inspection laboratory for a determination (“Inspection Lab”).  If Customer and Stellar do not agree on the selection or decision of the Inspection Lab, each of them shall hire its own Inspection Lab and the decision whether Defects exist shall be determined by the Courts in the Exclusive Venue.

 

19.)                           Exclusions of Consequential Damages.  STELLAR AGREES THAT CUSTOMER IS NOT LIABLE TO STELLAR FOR ANY CONSEQUENTIAL, PUNITIVE OR INCIDENTAL DAMAGES ARISING FROM CUSTOMER’S BREACH OF THIS AGREEMENT, EXCEPT THOSE CLAIMED BY A THIRD PARTY AGAINST STELLAR.

 

20.)                           Stellar’s Inability to Perform.  If Stellar ceases business operations or cannot conduct business operations for sixty (60) days or more, or if Stellar refuses to perform this Agreement, Customer may terminate this Agreement after giving Stellar sixty (60) days’ written notice to cure.  If Stellar fails to cure within such time period, Customer may terminate this Agreement for cause.  [***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

8

 

21.)                           Customer’s Obligations.  Until Customer has paid the Price in full, Customer shall fulfill all of its duties with respect to the Products and, in addition, shall:  [***].  Customer warrants that all information that it provides Stellar at any time regarding its creditworthiness and ability to perform this Agreement is true and accurate.

 

22.)                           Customer’s Default.  If Customer engages in any of the following, such action shall constitute a default by Customer under this Agreement (each, a “Default”):  (a) fails to make any payment when due; (b) materially violates any warranty or any other term of this Agreement or any Term contained in any Purchase Order or Purchase Order Acknowledgement (except for nonpayment of amounts due, which is governed by Section 22(a)); (c) materially violates any Laws, as defined in Section 28; (d) violates the terms of any other contract or agreement between Customer and Stellar (collectively “Other Contract[s]”); (e) becomes insolvent or makes an assignment for the benefit of creditors, is named as the debtor in any voluntary or involuntary bankruptcy proceeding, or has a receiver, liquidator or similar officer appointed to take charge of all or part of Customer’s assets, and such event is not cured or removed, to Stellar’s satisfaction, within sixty (60) days thereafter; or (f) attempts to assign or delegate any of its rights or obligations under this Agreement or any Purchase Order to any third party, except in the case of a Customer Sale or Product/Service Transfer.  For purposes of this Agreement, (A) a “Customer Sale” occurs if Customer merges with or is acquired by a third party, or transfers or assigns (i) control of its business to any third party or (ii) fifty percent (50%) or more of its assets, capital stock, voting stock or rights to profits to a third party, or intends to engage in any such activities and (B) a “Product/Service Transfer”occurs if Customer sells, licenses, transfers or assigns ownership of, or its right to manufacture or sell, any Products or Services (or any items which contain or use Products or Services), to a third party, or intends to engage in any such activity.  A Customer Sale and Product/Service Transfer is further governed by the terms of Sections 24 and 25.

 

23.)                           Remedies.  In the event of Default, Stellar is entitled to all remedies available at law and in equity and all other remedies provided in this Agreement.  Such remedies shall be [***] and include, without limitation:  (a) obtaining temporary restraining orders and temporary and permanent injunctions to compel performance, or to prevent or stop any violation; (b) [***]; (c) [***]; (d) [***]; (e) Stellar’s termination of this Agreement, any Purchase Orders and any Other Contracts, in Stellar’s discretion; and (f) [***].  However, the [***] within [***] days after the due date.  Any termination shall be without prejudice to any claims, damages or other rights that Stellar has or may have against Customer and any third party.  Stellar may exercise any combination of remedies without incurring any liability to Customer or any third party.  Customer agrees to indemnify and hold Stellar harmless from all claims by any third party arising from Stellar’s exercise of any of its remedies against Customer, and agrees to pay all of Stellar’s attorneys’ fees, costs and disbursements incurred in defending against any such third-party claims.

 

24.)                           [***] Triggering Events.  Customer agrees to [***] upon the earliest of the following:  (a) upon Customer’s failure to pay any amount when due under this Agreement if such Default is not cured within [***] days thereafter; (b) at the time of a Customer Sale or Product/Service Transfer (however, a Customer Sale or Product/Service Transfer is not a Triggering Event if Buyer assumes Customer’s obligations under this Agreement[***]); (c) at the time Customer no longer uses, markets, or manufactures any Product (unless Customer or Buyer fails to obtain FDA approval for such Product); (d) at the time Customer no longer orders 

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

9

 

or purchases any Product from Stellar (unless Customer or Buyer fails to obtain FDA approval for such Product); (e) at the time Stellar terminates this Agreement based upon Customer’s Default (subject to the provisions of Section 24(a)); (f) at the time Customer terminates this Agreement, including without limitation at the time of a Customer Voluntary Termination (excluding, however, a termination under Section 20); (g) upon the expiration of the first five-year Contract Term, unless Customer or Buyer failed to obtain FDA approval for any Product(s) and demonstrates that it is diligently pursuing FDA approval of the Product(s) at that time, in which case the [***] at the earliest of (1) the first alternative grounds under Section 24(a-f and h), (2) the expiration of the Contract Term, or [***] years after the [***]; and (h) upon the occurrence of any other event that [***] any Product (each, (a-h), a “Triggering Event”).

 

The Continuation Charge is calculated and defined as follows:

 

Regardless of any other term of this Agreement, Customer, on behalf of itself and any Buyer, agrees that under all circumstances Customer and any Buyer shall pay, and have a continuing duty to pay, Stellar the following continuing obligation for each Product, beginning the Effective Date:

 

·                  Percutaneous leads:  $[***]

 

·                  Percutaneous lead extenders:  $[***]

 

The continuing obligation payable for each Product is referred to as the “Continuation Charge” for that Product.  The Continuation Charge for each Product is incurred as of the Effective Date.  The Continuation Charge is calculated for each Product separately.  [***]

 

For example, if Customer purchases only [***] percutaneous leads from Stellar during the Contract Term, it must pay Stellar $[***] as a [***] for percutaneous leads as provided below.  If Customer purchases [***] percutaneous leads from Stellar, it must pay Stellar $[***] as a [***] for percutaneous leads as provided below.  This [***] is calculated as follows:  [***].  If Customer purchases [***] percutaneous leads during the Contract Term, it owes Stellar no [***] for the percutaneous leads; however, Customer would owe Stellar the [***] for percutaneous lead extenders until its purchases of percutaneous lead extenders exceed the [***] for that Product.  [***]

 

The Continuation Charge for each Product shall be [***] and payable upon the occurrence of the [***].  The [***] shall survive each of the events referenced in Section 24(a-h).

 

Customer agrees that the Continuation Charge is reasonable in all respects.  Customer agrees that Stellar has made and will make valuable and material investments in order to provide the Customer with the Products and Services referenced in this Agreement and in all Purchase Orders, including without limitation labor, skills, know-how, machinery and manufacturing processes.  Stellar has factored these investments and its expectation of the [***] into the Price of the Products.  Customer agrees that the value of Stellar’s investments [***].  The [***] is not a penalty.  Stellar and Customer have entered this Agreement only because of Customer’s agreement to the [***].

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

10

 

25.)                           Customer Sale and Product/Service Transfer(s).  In the event of a Customer Sale or Product/Service Transfer, Buyer may (in Customer’s and Buyer’s judgment) assume all of Customer’s obligations under this Agreement.  However, if Buyer refuses to assume any of the following obligations at the time of a Customer Sale or Product/Service Transfer, Customer shall remain liable for those amounts and shall pay Stellar such amount(s) [***]: (a) the [***]; (b) the cost of all (i) outstanding invoices; (ii) all finished Products and Services manufactured or provided by Stellar, including without limitation Products and Services in Stellar’s and Customer’s inventory and in shipment, (iii) all work in process (including Products and Services) and (iv) [***]; (c) all other sums owed by Customer under this Agreement and any Purchase Orders, including without limitation any damages for any Default under Section 23; and (d) in the event of a Customer Sale, all other sums owed by Customer under any Other Contracts, all of which (that is, (a-d)) shall be [***].  In the event of a Customer Sale, Product/Service Transfer or other transfer approved under Section 26, the parties to such transactions shall include terms in the related agreements that prevent Stellar’s competitors from obtaining or using Stellar’s Confidential Information and Intellectual Property as a result of such transactions, which terms must be approved in advance and in writing by the Chief Executive Officer of Stellar, in Stellar’s discretion.  All of Customer’s duties and obligations that survive this Agreement upon termination or expiration shall survive a Customer Sale and Product/Service Transfer.

 

26.)                           Binding Effect and Limitations on Assignability.  This Agreement binds each of the parties, their successors and assigns.  Notwithstanding any other term of this Agreement, Customer may not license, transfer or assign any of its rights or obligations under this Agreement or any Purchase Orders to any licensees, successors, transferees or assigns, including without limitation any subsidiaries, affiliates, parents or any third party, except pursuant to a Customer Sale or Product/Service Transfer, unless approved in advance and in writing by Stellar’s Chief Executive Officer, [***].

 

27.)                           Governing Law, Jurisdiction and Venue.  This Agreement and all Purchase Orders, and all rights and obligations arising thereunder, shall be governed exclusively by the laws of the State of Minnesota, without regard to Minnesota’s choice of law or conflict-of-law rules.  Customer consents to personal jurisdiction in the State and Federal Courts of Minnesota.  Any dispute relating to this Agreement shall only be filed and venued in the State Courts or Federal Courts of Minnesota (“Exclusive Venue”) and Customer waives all objections to venue in the Exclusive Venue, including forum non conveniens.  [***].

 

28.)                           Governmental Approvals and Warrants.  Customer agrees to comply with all international, foreign, federal (i.e., United States), State, municipal and local statutes, laws, regulations, ordinance and codes that apply to the Products and Services and to the performance of all or any part of this Agreement, with respect to the Products and Services (collectively, “Laws”).  Customer agrees to defend, indemnify and hold Stellar harmless from and against any and all claims (including civil damages, recalls, fines, awards, attorneys’ fees, costs and disbursements) arising from any violation of such Laws.  Customer warrants that this Agreement and all information, records, prototypes and other items furnished to Stellar do not violate any Laws or the rights of any third party.  Customer agrees to indemnify and hold Stellar harmless from and against all damages, recalls, penalties, costs, disbursements and attorneys’ fees resulting from its violation of the covenants in Section 28.

 

Stellar is [***] responsible for complying with Laws that [***].  Stellar’s failure to

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

11

 

comply with any Laws contained in any specifications shall be deemed a violation of Stellar’s Certificate of Conformance and Limited Warranty, and its liability shall be limited to the remedies provided to Customer under Section 18.

 

Stellar agrees to comply with all ISO certification requirements and State and federal laws governing its general business operations, including without limitation environmental laws (“General Business Laws”).  General Business Laws [***], as described in the first two paragraphs of this Section 28.  Stellar warrants that it will not employ any person who is debarred by the United States Food and Drug Administration (“FDA”) during the Contract Term.

 

29.)                           Severability and Waiver.  If any provision of this Agreement is held to be invalid or unenforceable by a court of competent jurisdiction, the enforceability of all remaining provisions of this Agreement will not be impaired and will remain in full force and effect.  If either Party fails to exercise, or delays its exercise of, any right, remedy, power or privilege under this Agreement, such failure or delay shall not operate as a waiver thereof in any later instance.  No waiver shall be effective unless it is in writing and is signed by an authorized officer of Stellar.

 

30.)                           Joint Signatures.  If more than one party signs this Agreement on behalf of Customer, including without limitation any personal guarantor or business guarantor, the term “Customer” shall mean all signing parties and guarantors, and all such parties shall be bound by all terms of this Agreement and shall be jointly and severally obligated hereunder.  All rights of Stellar shall inure to the benefit of its successors and assigns, and all obligations of Customer shall bind Customer’s permitted successors and assigns.

 

31.)                           Integration.  This Agreement including any Purchase Orders, Exhibits and Addenda contains the entire agreement between the parties concerning its subject matter and supersedes: (a) all other written and oral statements and agreements between the parties; (b) any prior course of dealing or industry practice; (c) any prior Confidentiality Agreement or Non-Disclosure Agreement between Stellar and Customer; and (d) any Customer Records (except Purchase Orders).  This Agreement may not be modified except in writing signed by the Chief Executive Officer of Stellar.

 

32.)                           No Joint Venture.  This Agreement does not create a joint venture or other business relationship between Stellar and Customer.  Stellar and Customer are, and at all times remain, separate and independent business entities.

 

	
STELLAR TECHNOLOGIES, INC.
    	
 
    	
NEVRO   CORP., a Delaware corporation
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
By:
    	
/s/   Estelle Forcelle
    	
 
    	
By:
    	
/s/   Konstantinos Alataris
    
	
 
    	
Estelle   Forcelle,
    	
 
    	
 
    	
Konstantinos   Alataris, Ph.D.
    
	
 
    	
Its:   Chief Executive Offifcer
    	
 
    	
 
    	
Its:   Chief Executive Offifcer
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
Date:
    	
7/13/09
    	
 
    	
Date:
    	
7/10/09
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

12

 

EXHIBIT A

 

PRICE TERMS

 

This Exhibit A (“Exhibit”) is incorporated into that certain Stellar Manufacturing Agreement (“Agreement”), by and between Stellar Technologies, Inc. (“Stellar”) and Nevro Corp. (“Customer”).  All terms defined in the Agreement shall have the same meaning in this Exhibit.  The terms of this Exhibit supersede any inconsistent terms of the Quotations, as defined below.

 

1.                                      The Agreement incorporates Stellar Quotation [***], dated [***] (“[***] Quotation”), and Stellar Quotation [***], dated [***] (“[***] Quotation”) (collectively, the [***] Quotation and [***] Quotation, the “Quotation[s]”).  The [***] Quotation is attached as Exhibit A-1 and the [***] Quotation is attached as Exhibit A-2.

 

2.                                      The Quotations list the unit price of the Products based on Stellar’s general understanding of Customer’s current designs and specifications for each Product.  If the final designs and specifications for the Products [***].  Similarly, if Customer modifies the drawings and specifications of any Products, the Parties will [***].  Finally, if the unit prices for any Products are not included in the Quotations and are later agreed upon by the Parties, the [***].  This would occur, for example, (a) if Stellar provides the cable for orders of [***] or more percutaneous leads; or (b) if Stellar provides the BAL seals for orders of [***] or more percutaneous lead extenders.  For purposes of this Exhibit and the Agreement, any [***] supersede the unit price of the Products listed in the Quotations.

 

3.                                      For each Product, the unit prices listed in the Quotations, subject to [***], are valid through the earlier of:  (a) [***], or (b) the date Stellar delivers the first [***] units of that Product.  The [***] unit threshold does not include the first [***] percutaneous leads or the first [***] percutaneous lead extenders.  If Stellar attains the [***] unit threshold with a Purchase Order that, when delivered within [***] months, results in Customer’s purchasing more than [***] units of either Product, the [***]

 

4.                                      Stellar will provide all materials for percutaneous leads under Item 001 of both Quotations.

 

5.                                      Stellar will provide all materials for percutaneous lead extenders, including BAL seals, under Item 003 of the [***] Quotation.

 

6.                                      Stellar will not provide BAL seals for percutaneous lead extenders under Item 002 of the [***] Quotation or under Item 004 of the [***] Quotation.  Instead Stellar will purchase the BAL seals at then-current market rates from the manufacturer and immediately charge Customer the sum of Stellar’s purchase price [***].

 

7.                                      If Customer orders a certain number of units of either Product at the related unit price, but then requests delivery more than [***] months after the date of the Purchase Order, Customer will pay the unit cost for that order based on the actual amount delivered during each [***] period beginning the date of the Purchase Order.  For example, if Customer orders [***] percutaneous lead extenders under Item 002 of the [***] Quotation but then requests delivery of [***] in the first [***] calendar months after the date of Purchase Order, and the remaining [***] in the next [***] calendar months, Customer will pay the unit price of the first [***] under Item

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

13

 

4 of the [***] Quotation ($[***] per unit) and the last [***] under Item 4 of the [***] Quotation ($[***] per unit), subject to [***].  Customer will not pay the unit price of [***] percutaneous lead extenders under Item 002 of the [***] Quotation ($[***] per unit).

 

EXHIBITS A-1 and A-2 follow

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

14

 

Our Quotation #[***]

[***]

 

	

9200 Xylon Avenue North
   Brooklyn Park, MN  55445
   763-493-8556  FAX 763-493-8507
    	
 
    

 

	
To:
    	
Andre Walker
    	
 
    	
 
    
	
 
    	
Nevro Corporation
    	
 
    	
Quotation Valid Thru : [***]
    
	
 
    	
411 Acacia Avenue
    	
 
    	
Terms : [***]
    
	
 
    	
Palo Alto CA 94306
    	
 
    	
 
    
	
 
    	
US
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
(650)251-0005
    	
 
    	
 
    

 

We are pleased to quote your requirements as shown below. Our company has a reputation for delivering quality products on time and we look forward to the opportunity of serving you. CONFIDENTIAL NOTICE: The information contained in this document and all attached documents is strictly confidential and contains proprietary information. It may only be used by the named addressee(s) and is also subject to the terms of any other confidentiality or nondisclosure agreement between parties. All other use is strictly prohibited.

 

	
Item
    	
 
    	
Part/Rev/Description/Details
    	
 
    	
Quantity Quoted
    	
 
    	
Unit Price $USD
    
	
001
    	
 
    	
[***]-XXXX
    	
U/M EA
    	
 
    	
[***]
    	
 
    	
[***]
    
	
 
    	
 
    	
Percutaneous   Lead
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Pricing   assumes [***], with deliveries [***] from order date. Pricing will be [***].
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Customer   Part: [***]-XXXX        Rev [***]
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
002
    	
 
    	
Perc.   Lead Extender
    	
U/M EA
    	
 
    	
[***]
    	
 
    	
[***]
    
	
 
    	
 
    	
Lead   Extension for Percutaneous lead
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Assumes   [***], with deliveries [***] of original order date. Pricing [***]. Stellar   will [***]. Pricing will be [***].
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Quoted   prices are based upon acceptance of shipments up to [***].  Delivery as quoted is [***], and will be   finalized [***]. This quotation is based on [***].
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Thank   you for your interest in Stellar Technologies as one of your suppliers.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
With   best regards,
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
[***]
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Terms   and Conditions of Sale:
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
General   Terms: All sales subject [***] terms and conditions of sales listed herein.   [***]
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Indemnification:   Upon Customers installation, use, manufacture, or an other operation   involving the components listed herein, [***].  Remedy: Subject to [***], in the event of a   breach of [***], Stellar’s [***] shall be as follows: [***]
    

 

***STELLAR NOW OFFERS CLEAN ROOM ASSEMBLY, MOLDING, COIL WINDING AND LASER MARKING/CUTTING/WELDING***

 

	
Customer
    	
Dennis Forcelle
    
	
 
    	
Authorized Signature
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

1

 

Our Quotation  #[***]

[***]

 

	

9200   Xylon Avenue North
   Brooklyn Park, MN  55445
   763-493-8556  FAX 763-493-8507
    	
 
    	
 
    

 

	
To:
    	
Andre Walker
    	
 
    	
 
    
	
 
    	
Nevro Corporation
    	
 
    	
Quotation Valid Thru : [***]
    
	
 
    	
411 Acacia Avenue
    	
 
    	
 
    
	
 
    	
Palo Alto CA 94306
    	
 
    	
 
    
	
 
    	
US
    	
 
    	
 
    

 

	
Item
    	
 
    	
Part/Rev/Description/Details
    	
 
    	
Quantity Quoted
    	
 
    	
Unit Price $USD
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

[***]. In no event shall [***]. STELLAR [***]. Stellar is [***]. Stellar’s [***] shall be as follows: [***]. In no event shall [***]. STELLAR [***].

 

***STELLAR NOW OFFERS CLEAN ROOM ASSEMBLY, MOLDING, COIL WINDING AND LASER MARKING/CUTTING/WELDING***

 

	
Customer
    	
Dennis Forcelle
    
	
 
    	
Authorized Signature
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

2

 

Our Quotation  #[***]

[***]

 

	

9200   Xylon Avenue North
   Brooklyn Park, MN  55445
   763-493-8556  FAX 763-493-8507
    	
 
    	
 
    

 

	
To:
    	
Andre Walker
    	
 
    	
 
    
	
 
    	
Nevro Corporation
    	
 
    	
Quotation Valid Thru : [***]
    
	
 
    	
411 Acacia Avenue
    	
 
    	
Terms : [***]
    
	
 
    	
Palo Alto CA 94306
    	
 
    	
 
    
	
 
    	
US
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
(650) 251-0005
    	
 
    	
 
    

 

We are pleased to quote your requirements as shown below. Our company has a reputation for delivering quality products on time and we look forward to the opportunity of serving you. CONFIDENTIAL NOTICE: The information contained in this document and all attached documents is strictly confidential and contains proprietary information. It may only be used by the named addressee(s) and is also subject to the terms of any other confidentiality or nondisclosure agreement between parties. All other use is strictly prohibited.

 

	
Item
    	
 
    	
Part/Rev/Description/Details
    	
 
    	
Quantity Quoted
    	
 
    	
Unit Price $USD
    
	
001
    	
 
    	
[***]-XXXX
    	
U/M EA 
    	
 
    	
[***]
    	
 
    	
[***]
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Percutaneous   Lead [***]
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Pricing goes into affect [***]. Pricing assumes [***], with   deliveries [***] from order date.
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Customer Part: [***]-XXXX            Rev   [***]
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
002
    	
 
    	
[***]-XXXX   
    	
U/M EA
    	
 
    	
[***]
    	
 
    	
[***]
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Percutaneous   Lead [***] 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Pricing goes into affect [***]. Pricing assumes [***], with   deliveries [***].
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Customer Part:   [***]-XXXX            Rev   [***]
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
003
    	
 
    	
Perc.   Lead Extender 
    	
U/M EA 
    	
 
    	
[***]
    	
 
    	
[***]
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Lead   Extension for Perc. Lead [***]
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Pricing assumes [***], with deliveries [***] from order date.
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
004
    	
 
    	
Perc.   Lead Extender 
    	
U/M EA
    	
 
    	
[***]
    	
 
    	
[***]
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Lead   Extension for Perc. Lead [***] 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Pricing assumes [***], with deliveries [***] from order date. Nevro   [***].
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

***STELLAR NOW OFFERS CLEAN ROOM ASSEMBLY, MOLDING, COIL WINDING AND LASER MARKING/CUTTING/WELDING***

 

	
Customer
    	
Dennis Forcelle
    
	
 
    	
Authorized Signature
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

1

 

Our Quotation  #[***]

[***]

 

	

9200 Xylon Avenue North
   Brooklyn Park, MN  55445
   763-493-8556  FAX 763-493-8507
    	
 
    	
 
    

 

	
To:
    	
Andre Walker
    	
 
    	
 
    
	
 
    	
Nevro Corporation
    	
 
    	
Quotation Valid Thru : [***]
    
	
 
    	
411 Acacia Avenue
    	
 
    	
 
    
	
 
    	
Palo Alto CA 94306
    	
 
    	
 
    
	
 
    	
US
    	
 
    	
 
    

 

	
Item
    	
 
    	
Part/Rev/Description/Details
    	
 
    	
Quantity Quoted
    	
 
    	
Unit Price $USD
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

	
 
    	
 
    	
Quoted   prices are based upon acceptance of shipments up to [***]. Delivery as quoted   is based on [***], and will be finalized [***], This quotation is based on   [***].
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Thank   you for your interest in Stellar Technologies as one of your suppliers.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
With   best regards,
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
[***]
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Terms   and Conditions of Sale:
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
General   Terms: All sales subject [***] terms and conditions of sales listed herein.   [***]
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Indemnification:   Upon Customer’s installation, use, manufacture, or an other operation   involving the components listed herein, [***]. Remedy: Subject to [***], in   the event of a breach of [***], Stellar’s [***] shall be as follows: [***].   In no event shall [***]. STELLAR [***]. Stellar is [***].  Stellar’s [***] shall be as follows: [***].   In no event shall [***]STELLAR IS [***]
    

 

***STELLAR NOW OFFERS CLEAN ROOM ASSEMBLY, MOLDING, COIL WINDING AND LASER MARKING/CUTTING/WELDING***

 

	
Customer
    	
Dennis Forcelle
    
	
 
    	
Authorized Signature
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

2Exhibit 10.3

 

SUPPLY AGREEMENT

 

This SUPPLY AGREEMENT (“Agreement”) is made as of this 23rd day of July, 2014 (the “Effective Date”), by and between Pro-Tech Design and Manufacturing, Inc., a California S corporation, having its principal place of business at 14561 Marquardt Ave., Santa Fe Springs, CA 90670 (“Pro-Tech”) and Nevro Corporation, a Delaware corporation, having its principal place of business at 4040 Campbell Avenue, Suite 210, Menlo Park, CA 94025 (“Nevro”).

 

WHEREAS, Pro-Tech provides contract manufacturing and packaging services to companies within the medical device industry;

 

WHEREAS, Nevro is engaged in the development of its proprietary implantable medical device for treating pain; and

 

WHEREAS, Nevro wishes to enter into a subsequent Supply Agreement for continued engagement with Pro-Tech to provide services relating to the inspection, labeling, packaging, and sterilization of Nevro’s medical device for use in Nevro’s commercial sale of Nevro’s medical device (“Purpose”), and Pro-Tech desires to provide such services.

 

NOW, THEREFORE, in consideration of the mutual covenants, terms and conditions set forth below, the parties agree as follows:

 

ARTICLE 1.
 DEFINITIONS

 

The following terms have the following meanings in this Agreement:

 

1.1                               “Accessory Components” means various Components packaged and supplied separately from a Product.

 

1.2                               “Affiliate(s)” means any corporation, firm, partnership or other entity, which controls, is controlled by or is under common control with a party.  For purposes of this definition, “control” shall mean the ownership of at least fifty percent (50%) of the voting share capital of such entity or any other comparable equity or ownership interest.

 

1.3                               “Applicable Laws” means all applicable laws, rules, regulations, standards and guidelines that apply to the performance of either party’s obligations under this Agreement, including without limitation current good manufacturing practice (“cGMP”) rules, regulations or standards promulgated by the FDA, international standards organizations, and any other governmental agency or any national industry association or governing body in any jurisdiction, including without limitation 21 C.F.R. § 802 et seq. and ISO 13485.

 

1.4                               “Component” means various components, pieces, or parts of the Product or the Accessory Components supplied to Nevro or its designee by Third Parties pursuant to Section 2.2 or manufactured by Pro-Tech pursuant to Section 2.1.

 

1.5                               “Confidential Information” has the meaning provided in Section 10.2.

 

1

 

1.6                               “Defective Product” means any Product or Accessory Component that contains a Nonconformity or Latent Defect.

 

1.7                               “Facilities” means Pro-Tech’s facilities located in [***] or such other facility as mutually agreed in writing by the parties.

 

1.8                               “FDA” means the United States Food and Drug Administration or any successor thereto.

 

1.9                               “Intellectual Property” means all patents, patent applications, know-how, trade secrets, copyrights, trademarks, designs, concepts, data, results, technical information, know-how, show-how, materials, prototypes, manuals, standard operating procedures, instructions or Specifications.

 

1.10                        “Latent Defect” means a Nonconformity that was not reasonably discoverable upon inspection pursuant to Article 4.1(b).

 

1.11                        “Losses” means suits, claims, losses, demands, liabilities, damages, costs and expenses (including reasonable attorneys’ fees) in connection with any suit, demand or action by any Third Party.

 

1.12                        “Nonconformity” means a characteristic, factor or circumstance of or relating to the Product or Accessory Component manufactured or supplied pursuant to this Agreement that renders Product or Accessory Component not to conform to the Specifications or not to have been made in accordance with Applicable Laws.

 

1.13                        “Packaging Supplies” include the Tray, retainer, lid, carton, and other packaging products that Pro-Tech will make or have made under this Agreement for packaging of Product or Accessory Components.

 

1.14                        “Product” means (i) an implantable pulse generator (an “IPG”), (ii) leads, and/or (iii) lead extenders (each packaged with a Tray) to be used in Nevro’s implantable medical device for treatment of chronic pain.

 

1.15                        “Regulatory Authority” means any governmental regulatory authority involved in regulating any aspect of the development, manufacture, market approval, sale, distribution, packaging or use of Nevro’s Products or Accessory Components including, but not limited to, the FDA and any foreign equivalents thereof.

 

1.16                        “Services” means the services performed by Pro-Tech pursuant to Sections 2.1, 2.2, and 2.3 of this Agreement.

 

1.17                        “Specifications” means the specifications for the Product and any Accessory Components, as set forth in Exhibit A of this Agreement, including the Tray Specifications and any subsequent changes to the Specifications or Tray Specifications made in accordance with Article 7.  The Specifications shall be attached to Exhibit A within forty-five (45) days after the Effective Date.

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

2

 

1.18                        “Third Party” means any person or entity other than Nevro, Pro-Tech, or an Affiliate of any of them.

 

ARTICLE 2.
 SERVICES

 

2.1                               Receipt and Inspection of Components.  Nevro will arrange for the supply to Pro-Tech of multiple Components by Third Parties.  Upon receipt of these Components so provided by or on behalf of Nevro, Pro-Tech shall inspect such Components for (i) damage, and (ii) compliance with other written requirements established by Nevro from time to time.  Pro-Tech shall notify Nevro of any damaged or non-compliant Components received within [***] business days after receipt of such Components.  If Pro-Tech discovers any damaged or non-compliant Component pursuant to (i) or (ii) above, subsequent to the above described notification of Nevro, Pro-Tech shall (a) ship such Component to an address designated in writing by Nevro, if requested by Nevro, and (b) not use or include any such Component when assembling or making the Product or any Accessory Component without Nevro’s prior written consent.  Pro-Tech shall store all Components received by or on behalf of Nevro in a manner that will not adversely harm such Components and that will preserve the functionality and integrity of such Components.  Pro-Tech is not responsible for any damaged or non-compliant Components, but will make reasonable efforts to discover such defects prior to packaging by performing an inspection on all Components it receives pursuant to this Agreement.  Nonetheless, upon prior written consent from Nevro, Pro-Tech may procure necessary Components from Third Parties on behalf of Nevro solely for the Purpose.  All material costs and expenses resulting from procuring Components on behalf of Nevro shall be charged [***] and invoiced [***] with all supporting documentation included.

 

2.2                               Environmental Monitoring Services. Pro-Tech will have systems in place to monitor the environment per Nevro’s requirement in which the products are manufactured and/or kitted and/or manufactured.

 

2.3                               Other Related Services.  Pro-Tech shall provide other services upon terms and conditions agreed to by the parties in writing from time to time.

 

2.4                               Performance by Pro-Tech.  Pro-Tech shall not delegate its responsibilities under this Agreement to any Third Parties or any Affiliates of Pro-Tech, without the prior written permission of Nevro, except that Pro-Tech may subcontract [***] to a Third Party that Nevro approves in writing.  In the event Nevro agrees to such a delegation of Pro-Tech’s responsibilities under this Agreement, Pro-Tech shall ensure such Third Party or Affiliate complies with the terms and conditions of this Agreement.  Any such delegation shall not relieve Pro-Tech of its responsibilities under this Agreement.

 

ARTICLE 3.
 PURCHASE ORDERS & FORECASTS

 

3.1                               Purchase Orders.  From time to time, Nevro may issue to Pro-Tech specific purchase orders for Product or Accessory Components (each a “Purchase Order”).  Individual Purchase Orders issued by Nevro referencing this Agreement will be the only documents

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

3

 

authorizing the supply of Products and Accessory Components to Nevro or its designee.  Each Purchase Order shall be in the form of a written or electronic communication and shall contain the following information: (i) a description of the Product and/or Accessory Components by item number and revision (ii) quantity and pricing of the Product and/or Accessory Components ordered; (iii) the required delivery date or shipping schedule; (iv) the location to which the Product and/or Accessory Components are to be shipped; and (v) [***] the method of transportation.

 

3.2                               Purchase Order Acceptance.  Pro-Tech shall acknowledge all Purchase Orders received from Nevro that are submitted in compliance with this Agreement in writing within [***] days after Pro-Tech receives such Purchase Order.  Pro-Tech will deliver all Product and/or Accessory Components prior to or on the delivery dates set forth on Purchase Orders that are so acknowledged, in accordance with Section 3.1.  Pro-Tech shall have no obligation to acknowledge any Purchase Order that either does not conform to Section 3.1 or that requires delivery in any calendar quarter of more than [***] of amounts of Product forecasted in the most recent forecast for such calendar quarter pursuant to Section 3.4.

 

3.3                               Adjustments to Purchase Orders.  Nevro may adjust any Purchase Order within [***] days after issuing a Purchase Order by changing the quantity of Products and/or Accessory Components ordered or rescheduling the delivery date. Subject to Section 2.2, Pro-Tech shall use commercially reasonable efforts to accommodate any other requested schedule changes.

 

3.4                               Forecast.  Nevro shall prepare and submit to Pro-Tech at least once per quarter a non-binding rolling six (6) month Product and Packaging Supplies demand forecast.  Each such forecast shall be non-binding and shall be used by Pro-Tech solely to plan for materials and production capacity.

 

ARTICLE 4.
 TESTING; SAMPLES; RELEASE

 

4.1                               Inspection; Acceptance.  Nevro shall be entitled to reject any portion or all of any shipment of Products or Accessory Components that are Defective Product.  Pro-Tech makes no claims for any Component of reliability, fitness of design, function, or compliance to the specifications for such Components, because such Components are procured by Nevro.

 

(a)                                 Pro-Tech shall maintain an inspection system adequate to ensure that all work performed and items delivered conform to the Specifications and that they comply with and are made in accordance with Applicable Laws and the terms of this Agreement.  Nevro may[***] inspect or test the work (including, without limitation, [***]) being performed under this Agreement, including without limitation [***] used for the performance of this Agreement.  If Nevro makes any inspection or test on the premises of the Pro-Tech, including the Facilities, or any permitted lower tier subcontractor pursuant to Section 2.5, all reasonable assistance for such inspection shall be provided by Pro-Tech [***].  Nevro shall be allowed to inspect Pro-Tech’s Facilities [***].  While on Pro-Tech’s premises, Nevro shall comply with Pro-Tech’s safety and security rules and regulations.

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

4

 

(b)                                 Within [***] business days after delivery of a shipment of Products or Accessory Components, Nevro or its designee may inspect such shipment.  Nevro shall promptly, and in no event more than [***] business days after the end of such inspection period, notify Pro-Tech if the shipment of Product or Accessory Components includes Defective Product.

 

(c)                                  If no such notice of Defective Product is provided by Nevro pursuant to Article 4.1(b), then Nevro shall be deemed to have accepted the shipment regardless of whether Nevro has actually performed any inspection or testing on such Product as set forth in Article 4.1(b), and Nevro shall be deemed to have waived any claims as to any Nonconformity, except as to Latent Defects as specified in Article 4.1(d).  Payment of invoice does not constitute acceptance of supplies covered by this Agreement and is without prejudice to any and all claims of Nevro against Pro-Tech.

 

(d)                                 If a shipment of Product has a Latent Defect, Nevro shall promptly, and in no event more than [***] business days after it becomes aware of such Latent Defect, notify Pro-Tech of such Latent Defect.

 

(e)                                  [***], Pro-Tech shall either repair or replace any such Defective Products, however Pro-Tech [***].  Pro-Tech shall promptly review the cause of rejection and upon confirmation take corrective action to address and correct the basis for any Nonconformity.  Pro-Tech shall bear [***] costs incurred by Pro-Tech in transporting such replacement Product to Nevro or its designee provided such Nonconformity be directly related to the work performed by Pro-Tech.

 

(f)                                   If Pro-Tech disputes Nevro’s assertion that certain Product or Accessory Components are Defective Products, then at either party’s request an independent testing laboratory reasonably acceptable to both parties and subject to confidentiality provisions set forth in Article 10 below, shall be engaged to analyze a sample of the allegedly Defective Product and any samples as necessary to determine whether such rejected Product or Accessory Components are Defective Products.  Both parties shall be bound by the laboratory’s results of analysis, which, absent manifest error, shall be deemed final as to any dispute under this Article 4.  If such laboratory determines Product contains a Nonconformity, then Pro-Tech shall be responsible for the costs incurred by such laboratory.  Otherwise, Nevro shall be responsible for the costs incurred by such laboratory.

 

4.2                               Chronic Defects.  Should a material number of Products or Accessory Component supplied by Pro-Tech pursuant to this Agreement in any given calendar quarter have Nonconformities, Pro-Tech shall promptly contact Nevro and provide information regarding the nature of the Nonconformities, the steps Pro-Tech plans to take to minimize the occurrence of such Nonconformities, and the frequency of occurrence of such Nonconformities.  Promptly after Nevro receives such notice, the parties shall meet to discuss the causes of such Nonconformities, develop a reasonable and mutually acceptable plan for minimizing occurrence of such Nonconformities, and use commercially reasonable efforts to perform their respective obligations under such plan.

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

5

 

ARTICLE 5.
 DELIVERY

 

5.1                               Storage and Delivery.  Pro-Tech shall segregate and properly store all Components provided by Nevro and Products and Accessory Components supplied by Pro-Tech until use or delivery.  Nevro shall [***].  Pro-Tech shall tender the Product or Accessory Components for delivery, [***] (Incoterms 2000) [***].  Pro-Tech shall ship Product or Accessory Components in accordance with the Purchase Order, or if not described therein, as Nevro designates.  Pro-Tech shall insure all Product or Accessory Components shipped to Nevro or its designee pursuant to this Agreement, at the cost of Nevro, and designate Nevro as the loss payee.

 

5.2                               Certificate of Compliance. Pro-Tech will provide a written certificate of compliance to Nevro indicating the Product or Accessory Components meet Specifications and were manufactured in accordance with, and comply with, other requirements under Applicable Laws.  Pro-Tech shall provide such certificate of compliance to Nevro electronically (via scanned and emailed copies) within [***] business day after each shipment of Product and in hard copy for the shipments during the preceding month within [***] business days after such month’s end.  Pro-Tech shall also include together with the foregoing, certificates of compliance Pro-Tech receives from Third Party suppliers of any Components included in such shipment pursuant to Section 2.2.  Pro-Tech [***] discover Defects through an inspection of Components it receives pursuant to this Agreement.

 

ARTICLE 6.
 PRICING AND PAYMENT

 

6.1                               Pricing.  Prices for the Products, each Accessory Components, and Packaging Supplies are or shall be set forth in Exhibit C, as may be amended from time to time upon mutual written agreement of the parties.  Pro-Tech represents that the prices for the Products Accessory Components, or Packaging Supplies sold to Nevro under this Agreement are [***].

 

6.2                               Taxes; Duty.  All taxes, duties and other amounts assessed on the Packaging Supplies prior to or upon sale to Nevro are the responsibility of Pro-Tech and are included in the pricing set forth on Exhibit C.

 

6.3                               Invoice; Payment Terms.  Pro-Tech shall invoice Nevro for all Products, Packaging Supplies, or Accessory Components shipped upon or after shipment.  Payment for such invoices shall be due within [***] days after shipment date.

 

ARTICLE 7.
 CHANGES TO SPECIFICATIONS

 

Any changes in the Specifications (“Changes”) from time to time shall be in writing, dated, and signed by the parties.  No Changes shall be implemented by Pro-Tech, whether requested by Nevro or requested or required by any Regulatory Authority, until the parties have mutually agreed in writing to such Change, the implementation date of such Change, and any increase or decrease in fees associated with such Change.  Pro-Tech shall respond promptly to

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

6

 

any request made by Nevro for a Change and both parties shall use commercially reasonable, good faith efforts to agree to the terms of such Change in a timely manner.  As soon as possible after Nevro or a Regulatory Authority requests any Change, Pro-Tech shall notify Nevro of the increase or decrease in fees associated with such change and shall provide such supporting documentation as Nevro may reasonably require.  Nevro shall pay all fees associated with such agreed upon Changes and agreed upon by the parties in writing.  Notwithstanding the forgoing, Pro-Tech shall not unreasonably withhold consent to Changes.

 

ARTICLE 8.
 RECORDS; REGULATORY MATTERS

 

8.1                               Records.  Pro-Tech shall maintain true and accurate books, records, test and laboratory data, reports and all other information (“Records”) relating to Services and manufacture or supply of Products or Accessory Components under this Agreement, including, without limitation, all information required to be maintained by Applicable Laws and any Regulatory Authority.  Pro-Tech shall provide Nevro with a copy of all Records and any documents related to the Services or the supply or manufacture of Product or Accessory Components at Nevro’s request or upon expiration or termination of this Agreement.  The Records shall be Confidential Information of Nevro.  Pro-Tech shall retain copies of all Records for a period of at least [***] years after [***].

 

8.2                               Regulatory Compliance.  Pro-Tech shall be solely responsible for all permits and licenses required by any Regulatory Authority or Applicable Laws to enable Pro-Tech to perform Services under this Agreement.  Pro-Tech will maintain ISO13485 certification.  For clarity, Nevro is responsible for all other permits and licenses required.  Pro-Tech will accommodate Nevro’s requests to perform periodic onsite audits.

 

8.3                               Quality Audits.  Inspection System and Quality Assurance Requirements for supplies and/or Services provided under this Agreement shall be in accordance with Pro-Tech’s standard quality system, which shall meet or exceed industry standards.  All Products and Accessory Components shall conform to the Specifications and shall be manufactured in accordance, and comply, with Applicable Laws and this Agreement.

 

8.4                               Regulatory Inspection.  Pro-Tech shall cooperate reasonably with Nevro’s efforts to obtain regulatory approval of Products. Without limiting the foregoing, if a Regulatory Authority makes an inquiry or otherwise requests information or assistance relating to Products or Accessory Components, whether to Nevro or Pro-Tech, Pro-Tech shall provide access to, and coordinate and make available, applicable personnel, facilities, materials, and documents as necessary to respond to such inquiries.  In the event of any such inquiry, request, or other communication relating to Product or Accessory Components, Pro-Tech will promptly notify and provide information regarding such inquiry, request, or communication to Nevro.  Pro-Tech will promptly forward to Nevro copies of any findings that Pro-Tech receives from a government authority or Regulatory Authority in connection with Services, Product, or Accessory Components.  Pro-Tech will also provide Nevro an opportunity to comment prospectively on any Pro-Tech responses to a government authority regarding Product or Accessory Components.

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

7

 

8.5                               Ownership of Regulatory Filings.  As between the parties, Nevro will own all regulatory filings for Nevro products.  Pro-Tech shall cooperate reasonably with Nevro to draft and file applications and other materials with any Regulatory Authority relevant to Products or Accessory Components, and to seek approval of Products by such Regulatory Authorities

 

ARTICLE 9.
 REPRESENTATIONS, WARRANTIES, AND COVENANTS

 

9.1                               Pro-Tech.  Pro-Tech represents, warrants and covenants to Nevro that:

 

(a)                                 In providing services under this Agreement, Pro-Tech shall comply with the Specifications, Applicable Laws and this Agreement;

 

(b)                                 neither Pro-Tech, its Affiliates, members of their respective staffs, nor any of their approved subcontractors or members of their respective staffs are or shall be, at the time of performance of under this Agreement, disqualified or debarred by any Regulatory Authorities or any other governmental authority for any purpose;

 

(c)                                  any Services provided hereunder by Pro-Tech will be provided in a workman-like and professional manner by personnel of Pro-Tech having a level of skill in the area commensurate with the requirements of the scope of work to be performed;

 

(d)                                 to its knowledge, its performance under this Agreement will not infringe or misappropriate any patent rights and other Intellectual Property rights;

 

(e)                                  all Product and Accessory Components shall comply with Specifications; and

 

(f)                                   it has not received any warnings from any Regulatory Authority relating to services it has provided to Third Parties.

 

9.2                               Mutual.  Each party hereby represents and warrants to the other party that:

 

(a)                                 Compliance with Laws.  Such party will comply with Applicable Laws relevant to such party’s performance under this Agreement.

 

(b)                                 Existence and Power.  Such party (i) is duly organized, validly existing and in good standing under the laws of the state in which it is organized and (ii) has the power and authority and the legal right to own and operate its property and assets, and to carry on its business as it is now being conducted.

 

(c)                                  Authorization and Enforcement of Obligations.  Such party (i) has the power and authority and the legal right to enter into this Agreement and to perform its obligations hereunder and (ii) has taken all necessary action on its part to authorize the execution and delivery of this Agreement and the performance of its obligations hereunder.

 

8

 

(d)                                 Execution and Delivery.  This Agreement has been duly executed and delivered on behalf of such party, and constitutes a legal, valid and binding obligation upon such party.

 

(e)                                  No Consents.  All necessary consents, approvals, and authorizations of all Regulatory Authorities and other persons required to be obtained by such party in connection with the Agreement have been obtained.

 

(f)                                   No Conflict.  The execution and delivery of this Agreement and the performance of such party’s obligations hereunder (i) do not conflict with or violate any requirement of Applicable Laws; and (ii) do not materially conflict with, or constitute a material default or require any consent under, any contractual obligation of such party.

 

9.3                               Limitations.  THE REPRESENTATIONS AND WARRANTIES SET FORTH IN THIS AGREEMENT ARE THE SOLE AND EXCLUSIVE REPRESENTATIONS AND WARRANTIES MADE BY EACH PARTY TO THE OTHER AND NEITHER PARTY MAKES ANY OTHER REPRESENTATIONS, WARRANTIES OR GUARANTEES OF ANY KIND WHATSOEVER, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OR FITNESS FOR A PARTICULAR PURPOSE.

 

ARTICLE 10.
 CONFIDENTIAL INFORMATION

 

10.1                        Mutual Obligation.  Pro-Tech and Nevro each agree that it will not disclose the Confidential Information (defined below) it receives from or on behalf of the other party pursuant to this Agreement to any Third Party without the prior written consent of the other party, or use such Confidential Information for any purpose other than as permitted in this Agreement or as necessary to perform its obligations or exercise its rights under this Agreement, except that Nevro may disclose this Agreement under confidentiality obligations to actual or potential outside investors, licensees, acquirers, corporate partners and advisors.  Notwithstanding the foregoing, each party may disclose the other party’s Confidential Information to any of its Affiliates, employees, consultants and other authorized representatives that (i) need to know such Confidential Information for the purpose of performing under this Agreement or exercising rights hereunder, (ii) are advised of the contents of this Article, and (iii) agree to be bound by the terms of this Article or confidentiality obligations commensurate with those set forth in this Article.

 

10.2                        Definition.  As used in this Agreement, the term “Confidential Information” includes all such information furnished by Pro-Tech or Nevro, or any of their respective authorized representatives, independent contractors or Affiliates, to the other or its authorized representatives, independent contractors or Affiliates, whether furnished in any form, including but not limited to written, verbal, visual, electronic or in any other media or manner.  Confidential Information includes without limitation all proprietary information (whether or not patented), any licensed technology, methods or materials, documents, analyses, compilations, business or technical information and other materials prepared by either party,

 

9

 

or any of their respective representatives, containing or based in whole or in part on any such information furnished to a party by the other party or its representatives.  Records, Specifications, Product or Component specific documents, and all copies thereof shall be deemed Confidential Information disclosed by Nevro.  Confidential Information of each party also includes without limitation the existence of this Agreement and its terms.  All Confidential Information will remain the sole property of the party disclosing or deemed to have disclosed such information or data.

 

10.3                        Exclusions.  Notwithstanding Article 10.1, the restrictions set forth in Article 10.1 shall not apply to any information that (i) is or becomes generally available to the public other than as a result of a breach of this Agreement, (ii) is already known by the receiving party at the time of disclosure, as evidenced by the receiving party’s written records, (iii) becomes available to the receiving party without an obligation of confidentiality, or (iv) was or is independently developed by or for the receiving party without reference to the other party’s Confidential Information, as evidenced by the receiving party’s contemporaneous written records.  If the Confidential Information of a party is required to be disclosed pursuant to a requirement of law, government regulation, or court or administrative order, then the party being compelled to disclose such Confidential Information may disclose such Confidential Information, provided that such disclosing party (a) gives the other party prompt written notice regarding such required disclosure so that the other party may obtain a protective order or otherwise minimize any such disclosure; (b) cooperates fully with the other party and/or its Affiliates in connection with its efforts to obtain any such order or other remedy; (c) discloses, where disclosure is necessary, only the information legally required to be disclosed; and (d) uses its reasonable efforts to have confidential treatment accorded to the disclosed Confidential Information.

 

10.4                        Return of Confidential Information.  Upon termination of this Agreement, the receiving party shall, upon request of the disclosing party, promptly return within [***] days all Confidential Information, including all copies thereof, and cease its use or, promptly destroy the same and certify such destruction to the disclosing party; except that the receiving party may retain a single copy thereof for the sole purpose of determining the scope of the obligations incurred under this Agreement.

 

10.5                        Survival.  The obligations of this Article 10 will terminate [***] years from the expiration or termination of this Agreement.

 

ARTICLE 11.
 INTELLECTUAL PROPERTY

 

11.1                        Pro-Tech Intellectual Property.  Pro-Tech has certain intellectual property rights over processes developed and trade secrets used in the manufacturing of Product.  If at any time Pro-Tech is unwilling or unable to provide Products or Accessory Components under this Agreement or after this Agreement terminates or expires, Pro-Tech grants Nevro a non-exclusive license under any intellectual property and/or know how and manufacturing processes owned or otherwise licensable by Pro-Tech to enable Nevro to make, have made, and use and sell the affected Product.

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

10

 

11.2                        Nevro Intellectual Property Relating to Products.  If Nevro makes any know-how or trade secret available to Pro-Tech relative to the design or production of a Product or Accessory Component, Pro-Tech will have a non-exclusive, non-transferable, revocable license under such intellectual property solely to produce or have produced the Products or Accessory Components pursuant to this Agreement.

 

ARTICLE 12.
 INDEMNIFICATION

 

12.1                        Indemnification by Pro-Tech.  Pro-Tech shall indemnify, defend and hold harmless Nevro, its Affiliates, and their respective directors, officers, employees and agents (“Nevro Indemnitees”) from and against any and all Losses to the extent arising out of or resulting from (i) any breach of Pro-Tech’s representations, covenants, warranties or obligations set forth in this Agreement or any Pro-Tech Indemnitee’s violation of Applicable Law relevant to this Agreement, or (ii) any negligence or willful misconduct by any Pro-Tech Indemnitee, except to the extent that any of the foregoing arises out of or results from any Nevro Indemnitees’ negligence, willful misconduct or breach of this Agreement or violation of Applicable Law.

 

12.2                        Indemnification by Nevro.  Nevro shall indemnify, defend and hold harmless Pro-Tech, its Affiliates, and their respective directors, officers, employees and agents (“Pro-Tech Indemnitees”) from and against any and all Losses to the extent arising out of or resulting from (i) any breach of Nevro’s representations, covenants, warranties or obligations set forth in this Agreement or any Nevro Indemnitee’s violation of Applicable Law relevant to this Agreement, or (ii) any negligence or willful misconduct by any Nevro Indemnitee, except to the extent that any of the foregoing arises out of or results from any Pro-Tech Indemnitees’ negligence, willful misconduct or breach of this Agreement or violation of Applicable Law.

 

12.3                        Indemnification Procedures.  All indemnification obligations in this Agreement are conditioned upon the party seeking indemnification: (i) promptly notifying the indemnifying party in writing of any claim or liability of which the party seeking indemnification becomes aware (including a copy of any related complaint, summons, notice or other instrument); provided, however, that failure to provide such written notice within a reasonable period of time shall not relieve the indemnifying party of any of its obligations hereunder except to the extent the indemnifying party is prejudiced by such failure; (ii) cooperating with the indemnifying party in the defense of any such claim or liability (at the indemnifying party’s expense); and (iii) not compromising or settling any claim or liability without prior written consent of the indemnifying party.  The indemnifying party may be represented by counsel of its own choosing, such counsel to be reasonably acceptable to the indemnified party.

 

ARTICLE 13.
 INSURANCE

 

Pro-Tech shall procure and maintain general liability insurance in such amount as ordinary good business practice for its type of business would make advisable, but not less than [***] dollars

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

11

 

($[***]).  Pro-Tech does not maintain insurance for Nevro’s products.  Nevro shall procure and maintain product liability and general liability insurance in such amount as ordinary good business practice for its type of business would make advisable, but not less than [***] dollars ($[***]).

 

ARTICLE 14.
 TERM AND TERMINATION

 

14.1                        Term.  This Agreement shall commence on the Effective Date and shall continue for a period of five (5) years, unless earlier terminated under Article 14.2 or 14.3 below (the “Term”).

 

14.2                        Termination for Material Breach.  Either party may terminate this Agreement effective upon sixty (60) days prior written notice to the other party, if the other party commits a material breach of this Agreement and fails to cure such breach by the end of such thirty (30) day period.

 

14.3                        Termination Without Cause.  Without prejudice to any of its other rights conferred on it by this Agreement or by Applicable Law:

 

(a)                                 Nevro may terminate this Agreement six (6) months after giving Pro-Tech written notice to such effect; and

 

(b)                                 Pro-Tech may terminate this Agreement eighteen (18) months after giving Nevro written notice to such effect.

 

14.4                        Effect of Termination.

 

(a)                                 Expiration or termination of this Agreement shall be without prejudice to any rights or obligations that accrued to the benefit of either party prior to such expiration or termination.

 

(b)                                 In the event of any termination pursuant to Section 14.2 or 14.3, Pro-Tech shall promptly return to Nevro (i) any remaining inventory of materials or Components received from or on behalf of Nevro, (ii) all remaining inventories of Product, (iii) any other Product (or Components thereof or raw materials therefor) being stored for Nevro, and (iv) copies of Records used to produce Product or Accessory Components, and all associated completed release tests and certificates of compliance.

 

(c)                                  Upon termination or expiration of this Agreement, all prototype tooling and production tooling shall be returned to Nevro from the location of such tooling at the time of such expiration or termination of this Agreement.  Pro-Tech may ship or send such tooling to Nevro, at Nevro’s cost, or Nevro may collect such tooling itself.

 

14.5                        Survival.  The provisions set forth in Section 14.4 and 14.5 and Articles 8, 10, 11, 12, 15, and 17 shall survive termination or expiration of this Agreement, as will other

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

12

 

terms that by their nature are intended to survive the expiration or termination of this Agreement.

 

ARTICLE 15.
 LIMITATIONS OF LIABILITY

 

EXCEPT IN CONNECTION WITH A BREACH OF A PARTY’S OBLIGATIONS UNDER ARTICLE 10 OR LIABILITY UNDER ARTICLE 12, NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY FOR INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR RELATED TO THIS AGREEMENT, INCLUDING WITHOUT LIMITATION, LOSS OF REVENUES, PROFITS OR DATA, WHETHER IN CONTRACT OR TORT, EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

 

ARTICLE 16.
 NOTICE

 

All notices and other communications hereunder shall be in writing to each party as set forth below and shall be deemed given: (i) when delivered personally; (ii) when delivered by facsimile transmission (receipt verified); (iii) when received or refused, if mailed by registered or certified mail (return receipt requested), postage prepaid; or (iv) when delivered if sent by express courier service, to the parties at the following addresses (or at such other address as specified by either party as described herein).

 

	
Nevro:
    	
 
    	
Nevro   Corporation
    	
 
    	
Pro-Tech:
    	
 
    	
Pro-Tech   Design & Manufacturing, Inc.
    
	
 
    	
 
    	
4040   Campbell Avenue,
   Suite 210
    	
 
    	
 
    	
 
    	
14561   Marquardt Ave.
    
	
 
    	
 
    	
Menlo   Park, CA 94025
    	
 
    	
 
    	
 
    	
Santa   Fe Springs, CA 90670
    
	
 
    	
 
    	
Tel:   650-251-0005
    	
 
    	
 
    	
 
    	
Tel:   562-207-1680
    
	
 
    	
 
    	
Facsimile:   650-251-9415
    	
 
    	
 
    	
 
    	
Facsimile:   562-207-1699
    

 

ARTICLE 17.
 MISCELLANEOUS

 

17.1                        Entire Agreement; Amendments.  This Agreement, the Exhibits thereto, and any amendments thereto constitute the entire understanding between the parties and supersede any contracts, agreements or understanding (oral or written) of the parties with respect to the subject matter hereof.  No term of this Agreement may be amended except upon written agreement of both parties, unless otherwise provided in this Agreement.

 

17.2                        Captions.  The captions and headings in this Agreement are for convenience only and are not to be interpreted or construed as a substantive part of this Agreement.

 

17.3                        Further Assurances.  The parties agree to execute, acknowledge and deliver such further instruments and to take all such other incidental acts as may be reasonably necessary or appropriate to carry out the purpose and intent of this Agreement.

 

13

 

17.4                        No Waiver.  Failure by either party to insist upon strict compliance with any term of this Agreement in any one or more instances will not be deemed to be a waiver of its rights to insist upon such strict compliance with respect to any subsequent failure.

 

17.5                        Severability.  If a court or other body of competent jurisdiction declares any term of this Agreement invalid or unenforceable, the remaining terms of this Agreement will continue in full force and effect.

 

17.6                        Independent Contractors.  The relationship of the parties is that of independent contractors, and neither party will incur any debts or make any commitments for the other party except to the extent expressly provided in this Agreement.  Nothing in this Agreement is intended to create or will be construed as creating between the parties the relationship of joint ventures, co-partners, employer/employee or principal and agent.

 

17.7                        Successors and Assigns.  This Agreement will be binding upon and inure to the benefit of the parties, their successors and permitted assigns.  Neither party may assign this Agreement, in whole or in part, without the prior written consent of the other party, which shall not be unreasonably withheld, provided, however, that either party may, without the other party’s consent, assign this Agreement to an Affiliate or to an acquirer or successor of substantially all of the business or assets of the assigning company to which this Agreement relates.  Any assignment in violation of this Section 17.7 shall be null and void.

 

17.8                        Governing Law.  This Agreement shall be governed by and construed under the laws of the State of Delaware, excluding its conflicts of law provisions.  The United Nations Convention on Contracts for the International Sale of Goods shall not apply to this Agreement.

 

17.9                        Counterparts.  This Agreement may be executed in one or more counterparts, each of which will be deemed an original but all of which together will constitute one and the same instrument.  Any photocopy, facsimile or electronic reproduction of the executed Agreement shall constitute an original.

 

17.10                       Product Release and Distribution.  Pro-Tech does not design or commercially distribute medical devices, components, or primary packaging elements.  Pro-Tech does not guarantee the fitness of use or reliability of any designs.  Nevro is solely responsible for the commercial distribution of its Products.  Pro-Tech may ship to multiple sites as requested by Nevro however Pro-Tech is not distributing the Product for Nevro.

 

[THE REMAINDER OF THIS PAGE LEFT BLANK
 SIGNATURES TO FOLLOW]

 

14

 

IN WITNESS WHEREOF, the parties have caused their duly authorized representative to execute this Agreement effective as of the Effective Date.

 

	
PRO-TECH DESIGN AND MANUFACTURING, INC.
    	
 
    	
NEVRO   CORPORATION
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
By:
    	
/s/   Aaron Swanson
    	
 
    	
By:
    	
/s/   Konstantinos Alataris
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
Name:
    	
Aaron   Swanson
    	
 
    	
Name:
    	
Konstantinos   Alataris
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
Title:
    	
VP,   Operations
    	
 
    	
Title:
    	
CEO
    

 

15

 

EXHIBIT A

 

SPECIFICATIONS

 

 

EXHIBIT B

 

QUALITY AGREEMENT

 

[Provided Separately]

 

 

EXHIBIT C

 

PRICING

 

 

	

    	
PRO TECH Design &   Mfg., Inc.
    
	
14561 Marquardt Avenue
    
	
Santa Fe Springs, CA 90670
    
	
Phone: (562) 207-1680
    
	
Fax: (562) 207-1698
    

 

Quotation [***][***]

 

	
Quote
    	
 
    	
Nevro   Corporation
    
	
To:
    	
 
    	
4040   Campbell Avenue 

Menlo   Park, CA 94025 

United   States
    

 

	
Quote   Number:
    	
 
    	
[***]
    	
 
    	
 
    	
 
    	
Contact:
    	
[***]
    
	
Quote   Date:
    	
 
    	
[***]
    	
 
    	
Expires: [***]
    	
 
    	
Inquiry:
    	
 
    
	
Customer:
    	
 
    	
NEVRO
    	
 
    	
 
    	
 
    	
Terms:
    	
[***]
    
	
Salesman:
    	
 
    	
[***]
    	
 
    	
 
    	
 
    	
Phone:
    	
[***]
    
	
Ship   Via:
    	
 
    	
[***]
    	
 
    	
 
    	
 
    	
FAX:
    	
[***]
    
	
[***]:
    	
 
    	
[***]
    	
 
    	
 
    	
 
    	
Delivery:
    	
[***]
    

 

Notes:

 

1)             [***]

 

2)             [***][***]

 

Part Number

 

	
Item
    	
 
    	
Descrition
    	
 
    	
Revision
    	
 
    	
Quantity
    	
 
    	
Price
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

1

 

Part Number

 

	
Item
    	
 
    	
Descrition
    	
 
    	
Revision
    	
 
    	
Quantity
    	
 
    	
Price
    
	
 
    	
 
    	
[***]
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

2

 

Part Number

 

	
Item
    	
 
    	
Descrition
    	
 
    	
Revision
    	
 
    	
Quantity
    	
 
    	
Price
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

3

 

Part Number

 

	
Item
    	
 
    	
Descrition
    	
 
    	
Revision
    	
 
    	
Quantity
    	
 
    	
Price
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    
	
[***][***]
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

4

 

Part Number

 

	
Item
    	
 
    	
Descrition
    	
 
    	
Revision
    	
 
    	
Quantity
    	
 
    	
Price
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
By   Aaron Swanson
    
	
 
    	
 
    	
 
    	
 
    	
PRO   TECH Design & Mfg., Inc.
    

 

5

 

 

The Point of Relief

 

	
Document Detail
    	
 
    	
[***]

1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 10
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                [***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 10
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 10
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 10
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 5 of 10
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 6 of 10
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 7 of 10
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 8 of 10
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 9 of 10
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 10 of 10
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
 
    	
[***]
   1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 2
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

4.                          RECEIVING INSPECTION REQUIRMENTS

 

[***]

 

5.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 2
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

6.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
 
    	
[***]
   1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 7
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 7
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

4.                          FUNCTIONAL REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 7
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

5.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 7
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 5 of 7
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 6 of 7
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

6.                          QUALITY SYSTEM

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 7 of 7
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

REVISION HISTORY

 

	
Rev
    	
 
    	
Change Description
    	
 
    	
Release
   Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
 
    	
[***]
   1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 2
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***]

 

3.3.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

4.                          FUNCTIONAL REQUIREMENTS

 

[***]

 

5.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 2
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

6.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
 
    	
[***]
   1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 2
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***]

 

3.3.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

4.                          FUNCTIONAL REQUIREMENTS

 

[***]

 

5.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 2
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

6.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
 
    	
[***]
   1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 7
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 7
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

4.                          FUNCTIONAL REQUIREMENTS

 

[***]

 

5.                          KIT SHALL BE EASY TO OPEN PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 7
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 7
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 5 of 7
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 6 of 7
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

6.                          QUALITY SYSTEM

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 7 of 7
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.2.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                         SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

REVISION HISTORY

 

	
Rev
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

REVISION HISTORY

 

	
Rev
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

REVISION HISTORY

 

	
Rev
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]

 

4.                         PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 6
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 6
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 6
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 6
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 5 of 6
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 6 of 6
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 5
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 5
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 5
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 5
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 5 of 5
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 4
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    	
 
    	
Supplier
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 3
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 8
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 8
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 8
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 8
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 5 of 8
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 6 of 8
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 7 of 8
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 8 of 8
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
 
    	
[***]
   1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 8
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 8
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 8
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 8
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 5 of 8
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 6 of 8
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 7 of 8
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 8 of 8
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
 
    	
[***]
   1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 5 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 6 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 7 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 8 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 9 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 5 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 6 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 7 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 8 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 9 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

 

The Point of Relief

 

	
Document Detail
    	
 
    	
[***]
   1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1   of 9
    
	
PART   SPECIFICATION
    	
Title
    
	
Confidential   & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 9
    
	
PART   SPECIFICATION
    	
Title
    
	
Confidential   & Proprietary
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 9
    
	
PART   SPECIFICATION
    	
Title
    
	
Confidential   & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 9
    
	
PART   SPECIFICATION
    	
Title
    
	
Confidential   & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document number

 

[***]
    	
Rev

 

[***]
    	
Sheet 5 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document number

 

[***]
    	
Rev

 

[***]
    	
Sheet 6 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document number

 

[***]
    	
Rev

 

[***]
    	
Sheet 7 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document number

 

[***]
    	
Rev

 

[***]
    	
Sheet 8 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document number

 

[***]
    	
Rev

 

[***]
    	
Sheet 9 of 9
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
DCN
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
 
    	
[***]
   1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 5 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 6 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 7 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 8 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 9 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 10 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 11 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 12 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
 
    	
[***]
   1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 5 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 6 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 7 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 8 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 9 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 10 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 11 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 12 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

The Point of Relief

 

	
Document Detail
    	
[***]
    
	
1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 5 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 6 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 7 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 8 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 9 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 10 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 11 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 12 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

 

 

The Point of Relief

 

	
Document Detail
    	
 
    	
[***]
   1
    

 

	
Type:
    	
 
    	
PRT_SPEC
    
	
Document No.:
    	
 
    	
[***]
    
	
Title:
    	
 
    	
[***]
    
	
Owner:
    	
 
    	
[***]
    
	
Status:
    	
 
    	
RELEASED
    
	
Effective Date:
    	
 
    	
[***]
    

 

	
Owner Role
    	
 
    	
Actor
    	
 
    	
Sign-off By
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 1 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

1.                          SCOPE

 

[***]

 

2.                          APPLICABLE DOCUMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 2 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

3.                          REQUIREMENTS

 

3.1.                   [***]

 

3.2.                   [***] bill of materials (BOM):

 

	
Nevro P/N
    	
 
    	
Supplier P/N
    	
 
    	
QTY
    	
 
    	
Description
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 3 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

3.3.                   [***]

 

4.                          PACKAGING & SHIPPING REQUIREMENTS

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 4 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 5 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 6 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 7 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 8 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 9 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 10 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 11 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

 

 

	

    	
Document   number

 

[***]
    	
Rev

 

[***]
    	
Sheet 12 of 12
    
	
PART SPECIFICATION
    	
Title
    
	
Confidential & Proprietary
    	
[***]
    

 

[***]

 

5.                          QUALITY SYSTEM

 

[***]

 

REVISION HISTORY

 

	
Rev
    	
 
    	
Change Description
    	
 
    	
Release Date
    
	
[***]
    	
 
    	
[***]
    	
 
    	
[***]
    

 

[***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}]]